The Center for Infecions Medicine (CIM) is a translational research center with a focus on immunology and infectious disease research, located in ANA Futura at Flemingsbergs campus in Huddinge.
- The Center is headed by Professor Anna Norrby-Teglund who has the overall responsibility for the administration and scientific development at CIM.
- Malin Flodström-Tullberg and Johan Sandberg are Deputy Unit Heads of CIM with shared responsibility for administration and scientific development.
- The Center is organized around 17 independent research groups, including the Management group.
A dynamic research environment
The Center for Infecions Medicine (CIM) comprises 750 square metres of fully equipped laboratory facilities in ANA Futura at Flemingsbergs campus in Huddinge. The main research activities are conducted here. Over the years, some research groups have had their main activities at the Department of Microbiology, Tumor- and Cell Biology at the Karolinska Institutet Solna Campus and the Swedish Institute for Infectious Disease Control (SMI).
Several group leaders have spent longer or shorter sabbaticals at international universities, and there is a continuous exchange of students and postdocs between the Center and other KI departments and national and international universities. By having groups at different locations and inviting researchers to work at the Center, research across disciplines is favored and the access to research infrastructures is increased.
Since its inauguration, CIM has successfully attracted some of the most talented young Swedish scientists actively engaged in human immunology and infectious disease research.
One of the main aims of CIM is to provide an environment and platform for the fostering of a new generation of research leaders within the fields of human immunology and infectious diseases. To date, several group leaders have promoted to full professors at Karolinska Institutet or have been appointed full professors at other national and international universities.
The history of CIM — From basic research to clinical trials
The first idea of establishing a new translational research center with a focus on immunology and infectious disease research came about in the year 2000. The inspiration came from the identified need for more and better translational research environments in Sweden, highlighted in two reports from the Swedish Cancer Society and the Swedish Research Council.Simultaneously, several international evaluations also emphasized the need of promoting translational research as well as creating better platforms for interactions between basic and clinical scientists.
In 2001, the creation of a new "Center for Infectious Medicine" at Karolinska Institutet was proposed by Professor Hans-Gustaf Ljunggren and Jan Andersson. It was proposed that research at the center should have a focus on basic and translational research within infection-immunity, with an intention to bring results of basic research at the center all the way to clinical trials. Furthermore, research at the center would have clinical questions of importance as grounds for the formulation of research projects.
Appropriate physical localities were provided by the Karolinska University Hospital at its Huddinge site, close to the clinical Infectious Disease Department in 2001. The hospital director at that time, Björn Rosén, was instrumental in this process. The Center for Infectious Medicine (CIM) was completed in 2002 and inaugurated in 2003.
In 2013 CIM celebrated it’s 10-year anniversary with an open day at the center and a symposium on the theme “CIM – History and Future”. Invited were Professor Hergen Spits, University of Amsterdam, who gave a lecture on the discovery of novel innate immune cells, and Professor Garry Nolan, Stanford University, who presented the, then, next generation flow cytometry – mass cytometry. The celebrations were attended by a large number of participants.
In the end of 2018, CIM moved to ANA Futura and continues to be a vibrant research environment.